ALZI Alzai Health Corp.

0.1852USD0.2650 CAD · TSXV0.00%Mkt Cap: 12.00M USDP/E: —

Alzai Health Corp., a healthcare technology company, provides artificial intelligence driven solution for risk screening. The company offers risk screening solutions for Mild Alzheimer's Disease and Mild Cognitive Impair…

Key Statistics

Company
Market Cap12.00M USD
Enterprise Value11.08M USD
Revenue (TTM)48.29K USD
Gross Profit-335.80K USD
Net Income (TTM)-2.57M USD
Revenue/Share0.0007 USD
Last Price0.1852 USD
Fiscal Year EndApr 2026
MR QuarterJul 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA02262P1036
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-3.97
EV/Revenue229.44
P/S248.54
P/B11.04
EPS (TTM)-0.05 USD
EPS (Forward)—
52W Range
0.104933% of range0.3495
52W High0.3495 USD
52W Low0.1049 USD
Profitability
Gross Margin0.00%
Oper. Margin-5783.60%
EBITDA Margin0.00%
Profit Margin-13593.12%
ROE278.29%
ROA-698.60%
ROIC—
ROCE—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.81M USD
CapEx (TTM)13.56K USD
FCF Margin—
FCF Yield—
Net Debt-922.51K USD
Net Debt/EBITDA0.33
Net Debt/FCF—
Balance Sheet
Debt/Equity-0.63
Current Ratio4.62
Quick Ratio4.54
Book Value/Sh0.02 USD
Cash/Share0.02 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.64.80M
Float55.90M
Insiders13.73%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short159
Short (prev mo.)744
Technical
SMA 500.1940 (-4.5%)
SMA 2000.2437 (-24.0%)
Beta—
S&P 52W Chg12.00%
Avg Vol (30d)18.97K
Avg Vol (10d)19.93K
Technical Indicators
RSI (14)62.2
MACD-0.0138
MACD Signal-0.0293
MACD Hist.+0.0155
BB Upper0.1831 USD
BB Middle0.1358 USD
BB Lower0.0885 USD
BB Width69.61%
ATR (14)0.0119 USD
Vol Ratio (20d)0.60x

About Alzai Health (CVE: ALZI)

›

Alzai Health (CVE: ALZI) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector.

The shares were at 0.2650 CAD on 19 November 2026. Its 52-week range is 0.1500 CAD to 0.5000 CAD: the price is 47.0% below the high and 76.7% above the low.

Its market capitalisation is 17.17M CAD.

Alzai Health reports return on equity of 278.3%.

It holds more cash than debt, a net cash position of 1.32M CAD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.